|
NCT02380573
|
2015-07-01 |
Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging and Mild Cognitive Impairment
|
Phase 2
|
Not Yet Recruiting
|
|
NCT02240498
|
2014-09-01 |
Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities
|
Phase 1
|
Recruiting
|
|
NCT01694966
|
2013-09-01 |
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
|
Phase 3
|
Recruiting
|
|
NCT01836094
|
2013-08-01 |
Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity
|
Phase 2
|
Enrolling By Invitation
|
|
NCT01668433
|
2013-07-01 |
Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
|
Phase 1
|
Recruiting
|
|
NCT01847612
|
2013-05-01 |
Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy
|
Phase 3
|
Recruiting
|
|
NCT01823172
|
2013-04-01 |
Second Echelon Node Study With Methylene Blue
|
Phase 1
|
Completed
|
|
NCT01657448
|
2013-03-01 |
Efficacy Study of Acriflavine Hydrochloride + Methenamine + Methylthioninium Chloride vs Placebo for the Rapid Relief of Symptoms Urinary Tract Infection
|
Phase 3
|
Not Yet Recruiting
|
|
NCT02295774
|
2013-02-01 |
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
|
Phase 2
|
Recruiting
|
|
NCT01797978
|
2013-02-01 |
Methylene Blue in Severe Sepsis and Septic Shock
|
Phase 3
|
Recruiting
|
|
NCT01407887
|
2011-08-01 |
Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children
|
Phase 2
|
Completed
|
|
NCT01386879
|
2011-07-01 |
Evaluation of Above the Cuff Suctioning During General Anesthesia
|
Phase 4
|
Terminated
|
|
NCT01276054
|
2010-12-01 |
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
|
Phase 2
|
Terminated
|
|
NCT01188694
|
2009-09-01 |
Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00354380
|
2006-09-01 |
Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study
|
Phase 2
|
Completed
|
|
NCT00784849
|
2004-11-01 |
Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
|
Phase 2
|
Completed
|
|
NCT00159510
|
2004-04-01 |
Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome
|
Phase 1
|
Active, Not Recruiting
|
|
NCT00214877
|
2003-11-01 |
Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
|
Phase 3
|
Completed
|